Postbiotics and the gut–brain axis: A mechanistic review on modulating neuroinflammation and cognitive aging

Jan 22, 2026Journal of neuroimmunology

Postbiotics and the gut-brain connection: How they may influence brain inflammation and memory aging

AI simplified

Gut-Brain Axis on OpenScience ↗PubMed ↗DOI ↗

Abstract

Elderly individuals show reduced microbial diversity and increased harmful bacteria, which may contribute to neuroinflammation and neurodegeneration.

Aging is associated with gut microbiota dysbiosis, leading to elevated levels of neurotoxic metabolites.
Reduced beneficial bacteria and increased pathobionts are observed in elderly gut microbiomes, correlating with neurodegenerative processes.
Inflammaging, characterized by chronic inflammation, is linked to the breakdown of the blood-brain barrier and activation of microglia.
Neuroprotective metabolites from gut bacteria may help maintain gut health, reduce inflammation, and promote brain health.
Postbiotics, derived from probiotics, appear to be safer and more effective than live probiotics in modulating the gut-brain axis.
Challenges in translating findings to humans include individual variability in gut microbiota and inconsistencies in metabolite absorption.

AI simplified

Aging triggers gut microbiota dysbiosis that disrupts the gut-brain axis (GBA), promoting neuroinflammation and neurodegeneration. Elderly exhibit reduced microbial diversity, depleted beneficial bacteria, and expanded pathobionts, elevating neurotoxic metabolites-lipopolysaccharides (LPS), trimethylamine-N-oxide, kynurenine derivatives, and secondary bile acids. These drive "inflammaging," blood-brain barrier breakdown, microglial activation, mitochondrial impairment, and proteinopathies in Alzheimer's and Parkinson's disease. Conversely, neuroprotective metabolites from commensals-short-chain fatty acids, indole-3-propionic acid, and urolithins-preserve gut integrity, suppress inflammation, upregulate BDNF for synaptic plasticity, and enhance mitophagy. Postbiotics, stable probiotic-derived bioactives (butyrate, polyphenol metabolites, and lactate derivatives), surpass live probiotics in safety and precision. They modulate GBA via histone deacetylase inhibition, GPR41/43 signaling, NF-κB blockade, and microglial M2 shift, blocking LPS translocation and bolstering neuronal resilience. Preclinical rodent studies demonstrate robust neuroprotection, but human translation reveals challenges: inter-individual microbiota variability (diet/genetics/comorbidities), inconsistent metabolite absorption/brain penetration between species, methodological limitations (16S rRNA vs. functional metagenomics), postbiotic standardization barriers, and sparse Phase I/II trials showing biomarker benefits without cognitive endpoints. This review synthesizes gut dysbiosis-metabolite-brain aging mechanisms, positioning postbiotics as precision therapeutics. Multi-omics stratified controlled trials are essential to validate long-term efficacy for delaying neurodegeneration and extending cognitive health.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Postbiotics and the gut–brain axis: A mechanistic review on modulating neuroinflammation and cognitive aging

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the gut-brain axis brief